Enveric Biosciences, Inc. (ENVB)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
Aug 24, 16:00
1.48
+0.07
(+4.96%)
After-Hours: 20:00
Enveric Biosciences Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 12.68% |
| September 30, 2019 | 14.62% |
| June 30, 2019 | 16.52% |
| March 31, 2019 | 14.78% |
| December 31, 2018 | 12.34% |
| September 30, 2018 | 16.16% |
| June 30, 2018 | 14.26% |
| March 31, 2018 | 13.76% |
| December 31, 2017 | 10.08% |
| September 30, 2017 | 13.94% |
| June 30, 2017 | 12.28% |
| March 31, 2017 | 21.17% |
| December 31, 2016 | 11.53% |
| September 30, 2016 | 11.80% |
| June 30, 2016 | 21.18% |
| March 31, 2016 | 43.29% |
| December 31, 2015 | 42.04% |
| September 30, 2015 | 32.05% |
| June 30, 2015 | 24.79% |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
| Date | Value |
|---|---|
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | 98.34% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 94.90% |
| Impact BioMedical, Inc. | -9.40K% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -190.1% |
| Return on Assets | -158.9% |
| Return on Invested Capital | -190.1% |
| Return on Net Operating Assets | -1.55K% |